Industry News

Bayer Diagnostic, a separate entity within the German pharmaceutical firm, is negotiating occupation of 70,000 sf in a yet-to-be built biotech laboratory and office building in Berkeley. The two-story facility, slated for completion in mid-2002, will be developed by Wareham Development of San Rafael, Ca. HKA Architects has been selected for the exterior drawings, with Darrell de Tienne providing conceptual design.  

Tularik Texas, a subsidiary of South San Francisco-based biotech firm Tularik, is leasing and building out a laboratory space in Dallas. The 2,300-sf facility will focus on anti-fungal and anti-bacterial drug development and is due to open in September.

Emmanuel College in Boston has partnered with Merck & Co. Inc. on a planned 300,000-sf research center. The Merck-owned facility on Emmanuel's 16-acre campus will foster a relationship between the college's biology students and Merck.   

Emerson College is planning several new developments, including a new residence hall and college center housing additional athletic and student activity space. Adjacent to the Majestic Theatre, Emerson has planned a $30 million, 11-story performance and production center containing offices, classrooms, laboratories, a television studio, an exhibition area, two small theaters, and dressing rooms for the Majestic, which will also be renovated.  

Boston College is undertaking several campus projects, including a $90 million renovation of the Higgins Science Building estimated to reach completion in fall of 2002. Construction has begun on a $36 million, 156,000-sf office facility on the lower campus, with plans for a $120 million development of three interconnected buildings (housing classrooms, offices, student services, and an auditorium) to follow.